Vitamin D/ Vitamin D Receptor Signaling Attenuates Skeletal Muscle Atrophy by Suppressing Renin‐Angiotensin System

Wen‐Xiong Li,Xian‐Hui Qin,Christina Chui‐Wa Poon,Man‐Sau Wong,Rui Feng,Jing Wang,Fu‐Hui Lin,Yue‐Li Sun,Shu‐Fen Liu,Yong‐Jun Wang,Yan Zhang
DOI: https://doi.org/10.1002/jbmr.4441
IF: 6.39
2021-09-29
Journal of Bone and Mineral Research
Abstract:The nutritional level of vitamin D may affect musculoskeletal health. We have reported that vitamin D is a pivotal protector against tissue injuries by suppressing local renin-angiotensin system (RAS). This study aimed to explore the role of vitamin D receptor (VDR) in the protection against muscle atrophy and the underlying mechanism. A cross-sectional study on participants (n = 1034) in Shanghai (China) was performed to analyze the association between vitamin D level and the risk of low muscle strength as well as to detect the circulating level of angiotensin II (Ang II). In animal studies, dexamethasone (Dex) was applied to induce muscle atrophy in wild-type (WT) and VDR-null mice, and the mice with the induction of muscle atrophy were treated with calcitriol for 10 days. The skeletal muscle cell line C2C12 and the muscle satellite cells were applied in in vitro studies. The increased risk of low muscle strength was correlated to a lower level of vitamin D (adjusted OR, 0.58) accompanied by an elevation in serum Ang II level. Ang II impaired the myogenic differentiation of C2C12 myoblasts as illustrated by the decrease in the area of myotubes and the down-regulation of myogenic factors (MHC & MyoD). The phenotype of muscle atrophy induced by Dex and Ang II was aggravated by VDR ablation in mice and in muscle satellite cells, respectively, and mediated by RAS and its downstream PI3K/Akt/FOXO1 signaling. Calcitriol treatment exhibited beneficial effects on muscle function as demonstrated by the increased weight-loaded swimming time, grip strength and fiber area, and improved fiber type composition via regulating ubiquitin ligases and their substrates MHC and MyoD through suppressing renin/Ang II axis. Taken together, VDR protects against skeletal muscle atrophy by suppressing RAS. Vitamin D could be a potential agent for the prevention and treatment of skeletal muscle atrophy.This article is protected by copyright. All rights reserved.
endocrinology & metabolism
What problem does this paper attempt to address?